Why do two people with the same cancer diagnosis—the same stage, the same cell type, and the same clinical profile—often have ...

Predictive genomics enhances breast cancer management by integrating predictive medicine, personal genomics, and translational bioinformatics for personalized care. Key applications include ...

In 2022, NIST started the Cancer Genome in a Bottle program as part of a major partnership between government, universities and industry to focus on fighting cancer. Specifically, the goal of the ...

An epigenetic mechanism by which tumors manage to hide from the body's immune defenses has just been described by an ...

Tissue's Dual-Analyte DNA and RNA Workflow Across 517 Cancer-Associated Genes, with ALK, RET and ROS1 Fusion Calls on ...

Trust is no longer enough: secure data sharing requires international collaboration across institutions and governments.

Hiroshima University researchers have developed a practical framework to identify candidate pathogenic variants hidden among the large number of variants of uncertain significance (VUS) detected in ...

Gallbladder cancer (GBC) is an extremely aggressive biliary tract malignancy characterized by silent early progression, ...

Collaboration with Dana-Farber Cancer Institute aims to identify biomarkers linked to treatment response for the next generation of cancer therapies and to define a clinical reporting framework to ...

In the same vein as weather forecast models that predict developing storms, researchers have now developed a method to predict the cell activity in tissues over time. The new software combines ...

In an effort to foster progress in cancer research, the National Institute of Standards and Technology (NIST) is releasing detailed and comprehensive data about the entire genetic content of a ...